Ada Zhong: Nice review by Janet Wui Cheung Kung and Kelvin Kwok Chai Ng
Quoting Ada Zhong, Science Editor of Hepatoma Research at OAE Publishing Inc., on LinkedIn:
”Nice REVIEW: Role of locoregional therapies in the management of patients with hepatocellular carcinoma.
Authors: Janet Wui Cheung Kung, Kelvin Kwok Chai Ng.
Article highlight: Ablative therapies have become the first-line treatment, as recommended by society guidelines for non-surgical patients with very early HCC achieving curative outcomes, while transarterial embolization techniques offer major benefit for patients with intermediate HCC.
Although patients with advanced HCC are currently limited to systemic therapy, the combination of locoregional and immune therapies shows promise in HCC management. PDF version. Author’s Talk.”
Source: Ada Zhong/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023